Skip to main content
. Author manuscript; available in PMC: 2023 Apr 14.
Published in final edited form as: Alzheimers Dement. 2022 Aug 15;19(4):1227–1233. doi: 10.1002/alz.12748

FIGURE 1.

FIGURE 1

Model of progression of biomarkers over the course of AD. Aβ42, amyloid beta monomer from amino acid 1 to 42; Aβi, intermediate amyloid beta; AD, Alzheimer’s disease; CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MCI, mild cognitive impairment; MRI, magnetic resonance imaging; PET, positron emission tomography